[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019-2023 Italy Hospital Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts

February 2019 | 394 pages | ID: 223D9D25A91EN
Venture Planning Group

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from LeadingMarketResearch.com

Contains 394 pages, 28 tables, and presents a comprehensive analysis of the Italian hospital hemostasis diagnostic testing market, including:
  • Major issues pertaining to the Italian coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Volume and sales forecasts for 40 coagulation procedures performed in Italian hospitals, including typical coagulation daily work loads.
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers.
  • Reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of coagulation technologies and their potential market applications.
  • Major opportunities for coagulation instruments and consumables.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 394 pages and 28 tables
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. INTRODUCTION
  2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
  3. ALPHA2 ANTIPLASMIN
  4. ANTITHROMBIN III
  5. BLEEDING TIME
  6. DDIMER
  7. ETHANOL FLOCCULATION TEST
  8. EUGLOBULIN LYSIS
  9. FACTOR ASSAYS
    a. INTRODUCTION
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. FIBRIN DEGRADATION PRODUCTS
  11. FIBRINOGEN
  12. HEPARIN
  13. HIRUDIN
  14. HYPERCOAGULABILITY AND THROMBOSIS
  15. LIPOPROTEIN A
  16. PLASMIN
  17. PLASMINOGEN
  18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
  19. PLATELET FUNCTION TESTS
  20. PLATELET AGGREGATION
  21. PROTEINS C AND S
  22. PROTHROMBIN FRAGMENT 1.2
  23. PROTHROMBIN TIME (PT)
  24. REPTILASE TIME
  25. THROMBIN TIME
  26. TISSUETYPE PLASMINOGEN ACTIVATOR (TPA)
  27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review

INTRODUCTION

Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STAR
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA50
Sysmex CA500
Sysmex CA1500
Sysmex CA5000/CA1000
Sysmex CA6000
Sysmex CA7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech CoagAMate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech CoagAMate MTX
Trinity Biotech CoagAMate RA4
Trinity Biotech CoagAMate XC/Plus
Trinity Biotech CoagAMate XM
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
  1. CHROMOGENIC SUBSTRATES
  2. MONOCLONAL AND POLYCLONAL ANTIBODIES
  3. IMMUNOASSAYS
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
    d. Fluorescent Immunoassays
Fluorescence Polarization
TimeResolved Pulse Fluorescence
Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. MICROCOMPUTERS
  5. AUTOMATION
  6. ROBOTICS
  7. DNA PROBES
    a. Overview
    b. Amplification Methods
PCR
Ligase Chain Reaction
Branched DNA
QBeta Replicase
NASBA
SDA
3 SR
HPA
TwoTiered System
LAT
  8. ARTIFICIAL INTELLIGENCE
  9. DRY CHEMISTRY
  10. BIOSENSORS
D. Worldwide Market Overview
  1. BUSINESS ENVIRONMENT
  2. MARKET STRUCTURE
  3. MARKET SIZE AND GROWTH
  4. POC TESTING MARKET
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized TESTING MARKETS
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
AxisShield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
ChronoLog
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory

ITC

Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing Ddimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's
Factor Tests
Executive Summary Table: Italy, Hospital Coagulation Diagnostics
Market By Product Category
Italy, Hospital Laboratories Performing Coagulation Tests By
Bed Size
Italy, Hospital Laboratories Average Daily Test Volume Italy, Hospital Laboratories Coagulation Test Volume by Assay
Italy, Major Suppliers of Coagulation Reagents Estimated
Sales and Market Shares Italy, Major Suppliers of Coagulation Analyzers
Estimated Sales and Market Shares Italy, Total Coagulation Diagnostics Market By Product Category
Italy, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares


More Publications